 |
|
Combined Methotrexate and Misoprostol for Early Induced Abortion
Pamela Ann Camosy, MD
Garden Ridge, Tex
Arch Fam Med. 1996;5(5):263-264.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
The recent article1 concerning chemical abortion using methotrexate and misoprostol calls for a response from family physicians who are opposed to elective abortions of any type. Most family physicians, indeed most gynecologists, refuse to perform abortions.2 Supporters of abortion are now touting chemical abortion as effective and safe. Do the authors believe that family physicians who will not perform surgical abortions will find chemical abortions any less objectionable?
Research into the use of methotrexate and synthetic prostaglandins for abortion has been presented in the gynecologic and pharmacologic literature for the past 4 years, and earlier this year to the medical community at large.3 Since discussion of chemical abortion has now entered the family practice literature, I would like to present another view.
Physicians have a unique position in the abortion debate. We are scientists who have intensively studied human life: its beginnings, its weaknesses and strengths, its
. . . [Full Text PDF of this Article]
|
